Botanical and Plant-DerivedDrugs-South America Market Status and Trend Report 2013-2023
Report Summary
Botanical and Plant-Derived Drugs-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Botanical and Plant-Derived Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of Botanical and Plant-Derived Drugs 2013-2017, and development forecast 2018-2023
Main market players of Botanical and Plant-Derived Drugs in South America, with company and product introduction, position in the Botanical and Plant-Derived Drugs market
Market status and development trend of Botanical and Plant-Derived Drugs by types and applications
Cost and profit status of Botanical and Plant-Derived Drugs, and marketing status
Market growth drivers and challenges
The report segments the South America Botanical and Plant-Derived Drugs market as:
South America Botanical and Plant-Derived Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America Botanical and Plant-Derived Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Terpenes and Steroids
Alkaloids and Glycosides
Phenols
Other
South America Botanical and Plant-Derived Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Fisheries
Fruits and Vegetables
Other
South America Botanical and Plant-Derived Drugs Market: Players Segment Analysis (Company and Product introduction, Botanical and Plant-Derived Drugs Sales Volume, Revenue, Price and Gross Margin):
Yunnan Baiyao
Tongrentang
Tasly
Sanjiu
Zhongxin
Haiyao
Taiji
Tsumura
Schwabe
Madaus
Weleda
Blackmores
Arkopharma
Sido Muncul
Arizona Natural
Dabur
Herbal Africa
Nature's Answer
Bio-Botanica
Zand
Nature Herbs
Imperial Ginseng
Kunming Pharma
JZJT
Guangzhou Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Botanical and Plant-Derived Drugs-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Botanical and Plant-Derived Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole South America and Regional Market Size of Botanical and Plant-Derived Drugs 2013-2017, and development forecast 2018-2023
Main market players of Botanical and Plant-Derived Drugs in South America, with company and product introduction, position in the Botanical and Plant-Derived Drugs market
Market status and development trend of Botanical and Plant-Derived Drugs by types and applications
Cost and profit status of Botanical and Plant-Derived Drugs, and marketing status
Market growth drivers and challenges
The report segments the South America Botanical and Plant-Derived Drugs market as:
South America Botanical and Plant-Derived Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Brazil
Argentina
Venezuela
Colombia
Others
South America Botanical and Plant-Derived Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Terpenes and Steroids
Alkaloids and Glycosides
Phenols
Other
South America Botanical and Plant-Derived Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Fisheries
Fruits and Vegetables
Other
South America Botanical and Plant-Derived Drugs Market: Players Segment Analysis (Company and Product introduction, Botanical and Plant-Derived Drugs Sales Volume, Revenue, Price and Gross Margin):
Yunnan Baiyao
Tongrentang
Tasly
Sanjiu
Zhongxin
Haiyao
Taiji
Tsumura
Schwabe
Madaus
Weleda
Blackmores
Arkopharma
Sido Muncul
Arizona Natural
Dabur
Herbal Africa
Nature's Answer
Bio-Botanica
Zand
Nature Herbs
Imperial Ginseng
Kunming Pharma
JZJT
Guangzhou Pharma
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BOTANICAL AND PLANT-DERIVED DRUGS
1.1 Definition of Botanical and Plant-Derived Drugs in This Report
1.2 Commercial Types of Botanical and Plant-Derived Drugs
1.2.1 Terpenes and Steroids
1.2.2 Alkaloids and Glycosides
1.2.3 Phenols
1.2.4 Other
1.3 Downstream Application of Botanical and Plant-Derived Drugs
1.3.1 Poultry
1.3.2 Fisheries
1.3.3 Fruits and Vegetables
1.3.4 Other
1.4 Development History of Botanical and Plant-Derived Drugs
1.5 Market Status and Trend of Botanical and Plant-Derived Drugs 2013-2023
1.5.1 South America Botanical and Plant-Derived Drugs Market Status and Trend 2013-2023
1.5.2 Regional Botanical and Plant-Derived Drugs Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Botanical and Plant-Derived Drugs in South America 2013-2017
2.2 Consumption Market of Botanical and Plant-Derived Drugs in South America by Regions
2.2.1 Consumption Volume of Botanical and Plant-Derived Drugs in South America by Regions
2.2.2 Revenue of Botanical and Plant-Derived Drugs in South America by Regions
2.3 Market Analysis of Botanical and Plant-Derived Drugs in South America by Regions
2.3.1 Market Analysis of Botanical and Plant-Derived Drugs in Brazil 2013-2017
2.3.2 Market Analysis of Botanical and Plant-Derived Drugs in Argentina 2013-2017
2.3.3 Market Analysis of Botanical and Plant-Derived Drugs in Venezuela 2013-2017
2.3.4 Market Analysis of Botanical and Plant-Derived Drugs in Colombia 2013-2017
2.3.5 Market Analysis of Botanical and Plant-Derived Drugs in Others 2013-2017
2.4 Market Development Forecast of Botanical and Plant-Derived Drugs in South America 2018-2023
2.4.1 Market Development Forecast of Botanical and Plant-Derived Drugs in South America 2018-2023
2.4.2 Market Development Forecast of Botanical and Plant-Derived Drugs by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Botanical and Plant-Derived Drugs in South America by Types
3.1.2 Revenue of Botanical and Plant-Derived Drugs in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Botanical and Plant-Derived Drugs in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Botanical and Plant-Derived Drugs in South America by Downstream Industry
4.2 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Brazil
4.2.2 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Argentina
4.2.3 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Venezuela
4.2.4 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Colombia
4.2.5 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Others
4.3 Market Forecast of Botanical and Plant-Derived Drugs in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
5.1 South America Economy Situation and Trend Overview
5.2 Botanical and Plant-Derived Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 BOTANICAL AND PLANT-DERIVED DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Botanical and Plant-Derived Drugs in South America by Major Players
6.2 Revenue of Botanical and Plant-Derived Drugs in South America by Major Players
6.3 Basic Information of Botanical and Plant-Derived Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Botanical and Plant-Derived Drugs Major Players
6.3.2 Employees and Revenue Level of Botanical and Plant-Derived Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BOTANICAL AND PLANT-DERIVED DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Yunnan Baiyao
7.1.1 Company profile
7.1.2 Representative Botanical and Plant-Derived Drugs Product
7.1.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Yunnan Baiyao
7.2 Tongrentang
7.2.1 Company profile
7.2.2 Representative Botanical and Plant-Derived Drugs Product
7.2.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tongrentang
7.3 Tasly
7.3.1 Company profile
7.3.2 Representative Botanical and Plant-Derived Drugs Product
7.3.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tasly
7.4 Sanjiu
7.4.1 Company profile
7.4.2 Representative Botanical and Plant-Derived Drugs Product
7.4.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Sanjiu
7.5 Zhongxin
7.5.1 Company profile
7.5.2 Representative Botanical and Plant-Derived Drugs Product
7.5.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Zhongxin
7.6 Haiyao
7.6.1 Company profile
7.6.2 Representative Botanical and Plant-Derived Drugs Product
7.6.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Haiyao
7.7 Taiji
7.7.1 Company profile
7.7.2 Representative Botanical and Plant-Derived Drugs Product
7.7.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Taiji
7.8 Tsumura
7.8.1 Company profile
7.8.2 Representative Botanical and Plant-Derived Drugs Product
7.8.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tsumura
7.9 Schwabe
7.9.1 Company profile
7.9.2 Representative Botanical and Plant-Derived Drugs Product
7.9.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Schwabe
7.10 Madaus
7.10.1 Company profile
7.10.2 Representative Botanical and Plant-Derived Drugs Product
7.10.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Madaus
7.11 Weleda
7.11.1 Company profile
7.11.2 Representative Botanical and Plant-Derived Drugs Product
7.11.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Weleda
7.12 Blackmores
7.12.1 Company profile
7.12.2 Representative Botanical and Plant-Derived Drugs Product
7.12.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Blackmores
7.13 Arkopharma
7.13.1 Company profile
7.13.2 Representative Botanical and Plant-Derived Drugs Product
7.13.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Arkopharma
7.14 Sido Muncul
7.14.1 Company profile
7.14.2 Representative Botanical and Plant-Derived Drugs Product
7.14.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Sido Muncul
7.15 Arizona Natural
7.15.1 Company profile
7.15.2 Representative Botanical and Plant-Derived Drugs Product
7.15.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Arizona Natural
7.16 Dabur
7.17 Herbal Africa
7.18 Nature's Answer
7.19 Bio-Botanica
7.20 Zand
7.21 Nature Herbs
7.22 Imperial Ginseng
7.23 Kunming Pharma
7.24 JZJT
7.25 Guangzhou Pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
8.1 Industry Chain of Botanical and Plant-Derived Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
9.1 Cost Structure Analysis of Botanical and Plant-Derived Drugs
9.2 Raw Materials Cost Analysis of Botanical and Plant-Derived Drugs
9.3 Labor Cost Analysis of Botanical and Plant-Derived Drugs
9.4 Manufacturing Expenses Analysis of Botanical and Plant-Derived Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Botanical and Plant-Derived Drugs in This Report
1.2 Commercial Types of Botanical and Plant-Derived Drugs
1.2.1 Terpenes and Steroids
1.2.2 Alkaloids and Glycosides
1.2.3 Phenols
1.2.4 Other
1.3 Downstream Application of Botanical and Plant-Derived Drugs
1.3.1 Poultry
1.3.2 Fisheries
1.3.3 Fruits and Vegetables
1.3.4 Other
1.4 Development History of Botanical and Plant-Derived Drugs
1.5 Market Status and Trend of Botanical and Plant-Derived Drugs 2013-2023
1.5.1 South America Botanical and Plant-Derived Drugs Market Status and Trend 2013-2023
1.5.2 Regional Botanical and Plant-Derived Drugs Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Botanical and Plant-Derived Drugs in South America 2013-2017
2.2 Consumption Market of Botanical and Plant-Derived Drugs in South America by Regions
2.2.1 Consumption Volume of Botanical and Plant-Derived Drugs in South America by Regions
2.2.2 Revenue of Botanical and Plant-Derived Drugs in South America by Regions
2.3 Market Analysis of Botanical and Plant-Derived Drugs in South America by Regions
2.3.1 Market Analysis of Botanical and Plant-Derived Drugs in Brazil 2013-2017
2.3.2 Market Analysis of Botanical and Plant-Derived Drugs in Argentina 2013-2017
2.3.3 Market Analysis of Botanical and Plant-Derived Drugs in Venezuela 2013-2017
2.3.4 Market Analysis of Botanical and Plant-Derived Drugs in Colombia 2013-2017
2.3.5 Market Analysis of Botanical and Plant-Derived Drugs in Others 2013-2017
2.4 Market Development Forecast of Botanical and Plant-Derived Drugs in South America 2018-2023
2.4.1 Market Development Forecast of Botanical and Plant-Derived Drugs in South America 2018-2023
2.4.2 Market Development Forecast of Botanical and Plant-Derived Drugs by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Botanical and Plant-Derived Drugs in South America by Types
3.1.2 Revenue of Botanical and Plant-Derived Drugs in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Botanical and Plant-Derived Drugs in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Botanical and Plant-Derived Drugs in South America by Downstream Industry
4.2 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Brazil
4.2.2 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Argentina
4.2.3 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Venezuela
4.2.4 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Colombia
4.2.5 Demand Volume of Botanical and Plant-Derived Drugs by Downstream Industry in Others
4.3 Market Forecast of Botanical and Plant-Derived Drugs in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
5.1 South America Economy Situation and Trend Overview
5.2 Botanical and Plant-Derived Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 BOTANICAL AND PLANT-DERIVED DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Botanical and Plant-Derived Drugs in South America by Major Players
6.2 Revenue of Botanical and Plant-Derived Drugs in South America by Major Players
6.3 Basic Information of Botanical and Plant-Derived Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Botanical and Plant-Derived Drugs Major Players
6.3.2 Employees and Revenue Level of Botanical and Plant-Derived Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BOTANICAL AND PLANT-DERIVED DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Yunnan Baiyao
7.1.1 Company profile
7.1.2 Representative Botanical and Plant-Derived Drugs Product
7.1.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Yunnan Baiyao
7.2 Tongrentang
7.2.1 Company profile
7.2.2 Representative Botanical and Plant-Derived Drugs Product
7.2.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tongrentang
7.3 Tasly
7.3.1 Company profile
7.3.2 Representative Botanical and Plant-Derived Drugs Product
7.3.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tasly
7.4 Sanjiu
7.4.1 Company profile
7.4.2 Representative Botanical and Plant-Derived Drugs Product
7.4.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Sanjiu
7.5 Zhongxin
7.5.1 Company profile
7.5.2 Representative Botanical and Plant-Derived Drugs Product
7.5.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Zhongxin
7.6 Haiyao
7.6.1 Company profile
7.6.2 Representative Botanical and Plant-Derived Drugs Product
7.6.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Haiyao
7.7 Taiji
7.7.1 Company profile
7.7.2 Representative Botanical and Plant-Derived Drugs Product
7.7.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Taiji
7.8 Tsumura
7.8.1 Company profile
7.8.2 Representative Botanical and Plant-Derived Drugs Product
7.8.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Tsumura
7.9 Schwabe
7.9.1 Company profile
7.9.2 Representative Botanical and Plant-Derived Drugs Product
7.9.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Schwabe
7.10 Madaus
7.10.1 Company profile
7.10.2 Representative Botanical and Plant-Derived Drugs Product
7.10.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Madaus
7.11 Weleda
7.11.1 Company profile
7.11.2 Representative Botanical and Plant-Derived Drugs Product
7.11.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Weleda
7.12 Blackmores
7.12.1 Company profile
7.12.2 Representative Botanical and Plant-Derived Drugs Product
7.12.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Blackmores
7.13 Arkopharma
7.13.1 Company profile
7.13.2 Representative Botanical and Plant-Derived Drugs Product
7.13.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Arkopharma
7.14 Sido Muncul
7.14.1 Company profile
7.14.2 Representative Botanical and Plant-Derived Drugs Product
7.14.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Sido Muncul
7.15 Arizona Natural
7.15.1 Company profile
7.15.2 Representative Botanical and Plant-Derived Drugs Product
7.15.3 Botanical and Plant-Derived Drugs Sales, Revenue, Price and Gross Margin of Arizona Natural
7.16 Dabur
7.17 Herbal Africa
7.18 Nature's Answer
7.19 Bio-Botanica
7.20 Zand
7.21 Nature Herbs
7.22 Imperial Ginseng
7.23 Kunming Pharma
7.24 JZJT
7.25 Guangzhou Pharma
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
8.1 Industry Chain of Botanical and Plant-Derived Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
9.1 Cost Structure Analysis of Botanical and Plant-Derived Drugs
9.2 Raw Materials Cost Analysis of Botanical and Plant-Derived Drugs
9.3 Labor Cost Analysis of Botanical and Plant-Derived Drugs
9.4 Manufacturing Expenses Analysis of Botanical and Plant-Derived Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF BOTANICAL AND PLANT-DERIVED DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
